In September, the WHO added GLP-1 therapies to its Essential Medicines List for managing Type 2 diabetes in high-risk groups.

Indian pharma ramps up global alignment, enforces strict ICH & WHO standards: Nandita Vijayasimha, Bengaluru Friday, December 5, 2025, 08:00 Hrs [IST] Indian pharma is acceleratin ...

Jamkas Pharmaceuticals, a Jammu-based Company, has announced the expansion of its third-party pharma manufacturing services ...

The WHO predicts that fewer than 10% of eligible patients will have access to GLP-1RAs by 2030.

Hyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (USFDA) concluded the ...

New guidelines from the World Health Organization (WHO) recommend using GLP-1 medications to help manage obesity along with a ...

Piramal Pharma Solutions, a global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd.

At GIJC25, Peruvian investigative journalist Fabiola Torres showed reporters how to uncover the systems behind pharma monopolies, and how to connect market structures to human impact.

The WHO compared the need to expand access to weight-loss drugs with the push for HIV drugs access in the 1980s.

This shift matters because the pharmaceutical industry carries material weight. The sector is estimated to be responsible for ...

In new treatment guidelines published this week, the WHO issued a “conditional recommendation” for GLP-1 medicines—including ...

Several changes have been made to EU chemicals policy and legislation with the aim of making society greener. These changes ...